Translating knowledge

IOCBTech is a technology transfer office and subsidiary company of IOCB (the Institute of Organic Chemistry and Biochemistry CAS). The company matches results of basic research done at the IOCB with needs of commercial partners to ultimately bring new ideas in medicinal chemistry, material sciences, and other fields of chemistry to human use.

Oxytocin

OXYTOCINTM

1958
Remestyp

TERLIPRESINTM

1965
Dermazulen

DERMAZULENTM

1969
Minirin

DESMOPRESINTM

1970
Usal

USALTM

1975
Adiuretin

ADIURETINTM

1975
Duvira gel

DUVIRA GELTM

1980
Duratocin

DURATOCINTM

1985
Vistide

VISTIDETM

1996

VIREADTM

2001

HEPSERATM

2002

TRUVADATM

2004

ATRIPLATM

2006

COMPLERATM

2011

STRIBILDTM

2012

Projects & Opportunities

Here you can explore our projects which are available for co-development or licensings.

About IOCB Tech

The IOCB Tech team supports management and decision-making processes in Target Research Groups of IOCB e.g. by due diligence analyses, market potential studies, and project feasibility evaluation. Moreover, the company is responsible for networking and industry partner search or negotiations of contracts and agreements in the field of intellectual property.

An integral part of IOCB Tech’s duties is the organization and development of spin-off companies on IOCB’s technology platform.

IOCB Team

News

02/23
2018

IOCB Tech at BioVaria 2018

02/23/2018
IOCB Tech is again one of the partners at the BioVaria conference. The event will take place April 23-24, 2018, in Munich, Germany BioVaria brings together European research institutions across national borders in order to improve the transfer of their research results into application. In…
01/11
2018

Featured Projects

01/11/2018
Three featured projects with self-explanatory videos. Please follow the link and like always if you would like to learn more about the projects and/or IOCB-TTO please don’t hesitate to contact us via email or phone. DIANA iBodies www.ibodies.eu rapid DNA staining…
11/11
2016

Lipeon pitch at BioVaria 2016

11/11/2016
If you are interested in the Lipeon Therapeutics project developed at the IOCB Prag, you can find Martin Fusek’s 5 minutes spin-off panel pitch at BioVaria 2016 here. For more information contact our IOCBTech team info@iocbtech.cz.
08/11
2016

Successful Basel Life Science Week

08/11/2016
Successful Basel Life-Science Week for IOCBTech, two oral presentations, two poster presentation and one 3rd poster price IOCB was successfully presenting four technologies at Basel Life Science Week September 19-22. Eva Kudova presented her work on “S.M.A.R.T. Steroids – NMDA Receptors Modulators Acting As CNS Therapeutics” and Vaclav Navratil his…
07/29
2016

New granted US patent

07/29/2016
LIPOPOLYAMINES OF SPERMINE TYPE FOR CONSTRUCTION OF LIPOSOMAL TRANSFECTION SYSTEMS Lukas Drasar and Miroslav Ledvina, from the  Institute of Organic Chemistry and Biochemistry (IOCB), invented in collaboration with Zina Korvasova and Jaroslav Turanek from the Faculty of Veterinary Medicine of the University of Veterinary and Pharmaceutical Science Brno, …
06/01
2016

Awarded US patent

06/01/2016
HELQUAT DERIVATIVES, PREPARATION THEREOF, AND USE THEREOF AS MEDICAMENTS Congratulations to  Filip Teply and Mirek Hajek, the patent application for there development of  “Helquat derviates” was granted in The United States. For more information about the patent please follow it on Espacenet. For more detail information on the…
04/29
2016

Patent awarded

04/29/2016
LIPIDATED PEPTIDES AS ANTI-OBESITY AGENTS Congratulations to  Lenka Maletinska, Blanka Zelezna, Miroslava Blechova and Andrea Spolcova, the patent application for their discovery on “Lipidated peptides as anti-obesity agent” was granted in Australia. For more information on the patent follow the link Espacenet . For more information on the…

Where to meet us?

Bio US

When: 04/06/2018 – 07/06/2018
Where: Boston, Massachusetts, USA (map)